Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FOLD | AZN | AMGN | GILD | GSK |
| Company | Amicus Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 14.32 | 212.66 | 373.50 | 156.01 | 61.54 |
| High | 14.35 | 212.71 | 380.58 | 156.01 | 61.69 |
| Low | 14.31 | 207.52 | 370.44 | 152.37 | 60.99 |
| Latest | 14.34 | 208.67 | 379.73 | 152.74 | 61.18 |
| Change | +0.04 | -0.81 | +6.37 | -2.53 | +0.31 |
| % Change | +0.28% | -0.39% | +1.71% | -1.63% | +0.51% |
| Volume | 3,118,300 | 2,604,100 | 2,731,900 | 5,190,800 | 5,390,000 |
| 20-Day Average Volume | 7,088,120 | 3,107,110 | 3,113,385 | 8,493,555 | 6,685,975 |
| Previous Close | 14.30 | 209.48 | 373.36 | 155.27 | 60.87 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.30 | 192.10 | 358.03 | 145.00 | 54.88 |
| 20-Day Raw Stochastic | 80.00% | 88.33% | 90.34% | 86.85% | 96.30% |
| 20-Day Relative Strength | 80.15 | 66.84 | 65.26 | 65.82 | 76.15 |
| Weighted Alpha | +66.34 | +50.62 | +34.81 | +49.83 | +80.69 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 64% Buy | 72% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 02/10/26 | +7.90% since 02/10/26 | +4.14% since 02/10/26 | +3.74% since 02/10/26 | +4.01% since 02/10/26 |
| Low | 14.30 on 02/17/26 | 199.19 on 02/11/26 | 361.00 on 02/11/26 | 147.38 on 02/11/26 | 58.01 on 02/11/26 |
| High | 14.36 on 02/11/26 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | +0.07% since 01/16/26 | +10.54% since 01/16/26 | +14.93% since 01/16/26 | +22.28% since 01/16/26 | +26.88% since 01/16/26 |
| Low | 14.26 on 02/06/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 47.62 on 01/20/26 |
| High | 14.36 on 02/11/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | +49.53% since 11/18/25 | +16.51% since 11/18/25 | +10.39% since 11/18/25 | +20.10% since 11/18/25 | +29.15% since 11/18/25 |
| Low | 9.31 on 11/21/25 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.81 on 11/20/25 |
| High | 14.38 on 01/14/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | +93.52% since 08/18/25 | +31.87% since 08/18/25 | +29.77% since 08/18/25 | +29.45% since 08/18/25 | +56.59% since 08/18/25 |
| Low | 7.28 on 08/19/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 14.38 on 01/14/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,501,584 | 323,627,968 | 204,700,304 | 189,501,472 | 124,709,680 |
| Shares Outstanding, K | 313,918 | 1,550,908 | 539,068 | 1,240,680 | 2,038,406 |
| Annual Sales | 528,300,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -56,110,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 169,060,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | 17,310,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 0.38 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.17 on 11/04/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 02/18/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.478 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 357.50 | 25.86 | 17.09 | 19.05 | 13.47 |